Email

MEDICA 2023 took place in Dusseldorf, Germany, from 13 to 16 November. MEDICA is a global comprehensive exhibition of medical equipment and technology, attracting the world's well-known industry brands to the event every year. As one of the world's leading brand of full-scene oxygen production solutions, Canta Medical participated in this exhibition, and "China's intelligent manufacturing" blossomed on the international stage.


Canta-Medical-attend-MEDICA-2023-1.jpg


Canta-Medical-attend-MEDICA-2023-2.jpg


At the exhibition, the Canta medical team presented the core advantages of canta medical oxygen production and the results of the whole scene to customers at home and abroad. The exhibition hall was crowded with people, and customers came to consult and negotiate in an endless stream. At the same time, Canta fully responds to the urgent demand of the current international market for high-quality oxygen supply, and its oxygen products have won wide praise for their innovative research and development and advanced technology, becoming the focus of popularity on the scene.


Canta-Medical-attend-MEDICA-2023-3.jpg


In recent years, Canta Medical has actively expanded overseas business in the whole scene oxygen production vertical field, with exclusive signing of large agent dealers in 28 countries around the world, completed product registration in 18 countries and regions such as Russia, Japan, South Korea, and provided OEM services for large dealers in many countries/regions. Relying on the hard power of its products, Canta Medical reached procurement cooperation with international organizations such as the World Health Organization (WHO). During the epidemic prevention and control period, Canta Medical provided product support for UNICEF's epidemic prevention and control, and further expanded its brand influence in the international scope.


Canta-Medical-attend-MEDICA-2023-4.jpg


Canta-Medical-attend-MEDICA-2023-5.jpg


At present, the Canta Medical MEDICA 2023 trip has come to a successful end, Canta Medical will continue to adhere to technological innovation, accelerate the pace of market expansion, and work with partners to contribute more to the global oxygen industry.